Case Series of Angioembolization of Genitourinary System Between 2004 and 2016

Author:

Heidari Ramin,Behjati MohaddesehORCID,Alizadeh Sani Zahra,Alizadehsani Roohallah

Abstract

Background: Endourologic or percutaneous interventional treatments in genitourinary (GU) is a growing field of science with the advent of improved imaging techniques and smaller catheters. Hereby, we report case series of endovascular GU angioembolization procedures performed in our center. Methods: In this study, we report cases who underwent successful angioembolization. A total of 76 cases of bladder transitionary cell carcinoma cells, 8 cases of bladder and renal arteriovenous malformation (AVMs), 33 cases with hematuria after percutaneous nephrolithotomy (PCNL), 29 cases of renal angio-myolipoma, 3 benign prostatic hyperplasia (BPH) cases high risk for surgery and 5 cases of hematuria in the setting of acute renal trauma had undergone GU endovascular treatment. Results: The success rate for angioembolization of bladder transitionary carcinoma cell was 100% but in 2 cases hematuria continued due to another GU source. Coil embolization of bladder and renal AVMs and renal angio-myolipoma were successful in all cases. Cessation of hematuria after PCNL was successful in all cases except one. Coli embolization of BPH and hematuria due to renal trauma were ceased in all cases. Complications included easily controllable hematoma in 3 cases. Contrast induced nephropathy and fever occurred in 12% and 20%, respectively. Pain duration was within 4 - 10 days after embolization of AVM or tumor. Embolization could be done in high output priapism and varicocel but we did not perform these procedures because of no referral. Conclusions: Coil embolization of GU system is quite safe and approved method and could be used with high success rate and low failure rate.

Publisher

Briefland

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3